Vertex Pharmaceuticals Change in Inventories decreased by 41.0% to $77.40M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 47.5%, from $147.50M to $77.40M. Over 4 years (FY 2021 to FY 2025), Change in Inventories shows an upward trend with a 54.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase might signal preparation for a major product launch or, conversely, slowing demand and potential future write-downs.
This metric tracks the change in the value of raw materials, work-in-progress, and finished goods held by the company. A...
Consumer hardware companies aim for high inventory turnover to minimize the risk of product obsolescence.
cf_change_in_inventories| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $24.71M | $18.34M | $26.97M | -$2.00M | $33.30M | $26.80M | $78.30M | $82.60M | $72.80M | $97.50M | $70.00M | $80.10M | $107.20M | $182.50M | $147.50M | $167.10M | $148.60M | $131.10M | $77.40M |
| QoQ Change | — | -25.8% | +47.1% | -107.4% | >999% | -19.5% | +192.2% | +5.5% | -11.9% | +33.9% | -28.2% | +14.4% | +33.8% | +70.2% | -19.2% | +13.3% | -11.1% | -11.8% | -41.0% |
| YoY Change | — | — | — | — | +34.8% | +46.2% | +190.3% | >999% | +118.6% | +263.8% | -10.6% | -3.0% | +47.3% | +87.2% | +110.7% | +108.6% | +38.6% | -28.2% | -47.5% |